Author: CCH Incorporated
Publisher: Wolters Kluwer
ISBN: 9780808011293
Category : Business & Economics
Languages : en
Pages : 642
Book Description
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Author: CCH Incorporated
Publisher: Wolters Kluwer
ISBN: 9780808011293
Category : Business & Economics
Languages : en
Pages : 642
Book Description
Publisher: Wolters Kluwer
ISBN: 9780808011293
Category : Business & Economics
Languages : en
Pages : 642
Book Description
Description of the Prescription Drug and Medicare Improvement Act of 2003
Author: United States. Congress. Senate. Committee on Finance
Publisher:
ISBN:
Category : Aged
Languages : en
Pages : 108
Book Description
Publisher:
ISBN:
Category : Aged
Languages : en
Pages : 108
Book Description
108-1 Committee Print: Description of The Prescription Drug and Medicare Improvement Act of 2003, S. Prt. 108-29, June 2003, *
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 108
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 108
Book Description
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Author: United States. Congress
Publisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 850
Book Description
Publisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 850
Book Description
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (H.R. 1).
Author: CCH Incorporated
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 681
Book Description
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 681
Book Description
Medicare Prescription Drug and Modernization Act of 2003
Author: United States. Congress. House. Committee on Energy and Commerce
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 300
Book Description
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 300
Book Description
Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Author: Jennifer O'Sullivan
Publisher:
ISBN:
Category : Health insurance
Languages : en
Pages : 24
Book Description
This report examines the the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, which creates a prescription drug benefit for Medicare beneficiaries and establishes a new Medicare Advantage program to replace the current Medicare+Choice program.
Publisher:
ISBN:
Category : Health insurance
Languages : en
Pages : 24
Book Description
This report examines the the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, which creates a prescription drug benefit for Medicare beneficiaries and establishes a new Medicare Advantage program to replace the current Medicare+Choice program.
H.R. 1, Medicare Prescription Drug and Modernization Act of 2003
Author: United States. Congress. House. Committee on Rules
Publisher:
ISBN:
Category : Bills, Legislative
Languages : en
Pages : 136
Book Description
Publisher:
ISBN:
Category : Bills, Legislative
Languages : en
Pages : 136
Book Description
Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.